Trial intelligence / Profile preview

Related Mechanisms of RBP4 in Glycolipid Metabolism

NCT05576168Completed

Sponsor
Shanghai Tenth People's Hospital
Start
May 2018
Primary completion
Jun 2020
Countries
1
01

Overview

Open-label trial (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Retinol Binding Protein 4 at 3 years. Started May 2018; status: completed.

Beyond the preview

Go deeper on NCT05576168.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05576168.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call